Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study.

<p><strong>Objectives:</strong> Recruitment to pragmatic trials is often difficult, and little is known about factors associated with key participation and treatment decisions. These were explored in the Prostate cancer testing and Treatment (ProtecT) study.</p> <...

תיאור מלא

מידע ביבליוגרפי
Main Authors:	Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group
פורמט:	Journal article
שפה:	English
יצא לאור:	Elsevier 2019

פריטים דומים

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial
מאת: Donovan, JL, et al.
יצא לאור: (2017)

Prostate Testing for Cancer and Treatment (ProtecT) feasibility study
מאת: J. Donovan, et al.
יצא לאור: (2003-01-01)

Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study
מאת: Young, GJ, et al.
יצא לאור: (2017)

Addressing patient treatment preferences at trial recruitment.
מאת: Mills, N, et al.
יצא לאור: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials
מאת: Mills, N, et al.
יצא לאור: (2011)

Exploring treatment preferences facilitated recruitment to randomized controlled trials.
מאת: Mills, N, et al.
יצא לאור: (2011)

Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
מאת: Lane, A, et al.
יצא לאור: (2016)

Factors distinguishing general practitioners who more readily participated in a large randomized trial were identified.
מאת: Down, L, et al.
יצא לאור: (2009)

Addressing patient treatment preferences at trial recruitment
מאת: Mills Nicola, et al.
יצא לאור: (2011-12-01)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
מאת: Donovan, J, et al.
יצא לאור: (2003)

Systematic review and meta-analysis of the associations between body mass index, prostate cancer, advanced prostate cancer, and prostate-specific antigen
מאת: Harrison, S, et al.
יצא לאור: (2020)

The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation
מאת: Rooshenas, L, et al.
יצא לאור: (2018)

A comparison of socio-demographic and psychological factors between patients consenting to randomisation and those selecting treatment (the ProtecT study).
מאת: Mills, N, et al.
יצא לאור: (2006)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
מאת: Turner, E, et al.
יצא לאור: (2011)

Radiotherapy for prostate cancer: is it 'what you do' or 'the way that you do it'? A UK perspective on technique and quality assurance.
מאת: Mason, MD, et al.
יצא לאור: (2016)

Low risk research using routinely collected identifiable health information without informed consent: encounters with the Patient Information Advisory Group.
מאת: Metcalfe, C, et al.
יצא לאור: (2008)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC)
מאת: Wade, J, et al.
יצא לאור: (2017)

Characteristics of men responding to an invitation to undergo testing for prostate cancer as part of a randomised trial.
מאת: Walsh, E, et al.
יצא לאור: (2016)

Experiences and decision processes during PSA testing and prostate biopsy: A qualitative study
מאת: Avery, K, et al.
יצא לאור: (2007)

Seasonal variation in prostate-specific antigen levels: A large cross-sectional study of men in the UK
מאת: Down, L, et al.
יצא לאור: (2011)

Prostate-specific antigen testing and prostate biopsy: are self-reported lower urinary tract symptoms and health-related quality of life associated with the decision to undergo these investigations?
מאת: Avery, K, et al.
יצא לאור: (2008)

Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
מאת: Macefield, R, et al.
יצא לאור: (2009)

Seasonal variation in prostate-specific antigen levels: a large cross-sectional study of men in the UK.
מאת: Down, L, et al.
יצא לאור: (2011)

Latest results from the UK trials evaluating prostate cancer screening and treatment: the CAP and ProtecT studies.
מאת: Lane, J, et al.
יצא לאור: (2010)

Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer
מאת: Hamdy, FC, et al.
יצא לאור: (2023)

ProDiet: A phase II randomized placebo-controlled trial of green tea catechins and lycopene in men at increased risk of prostate cancer
מאת: Lane, JA, et al.
יצא לאור: (2018)

Effect of a low-intensity PSA-based screening intervention on prostate cancer mortality: The CAP randomized clinical trial
מאת: Martin, RM, et al.
יצא לאור: (2018)

ASSOCIATIONS OF SEXUAL DYSFUNCTION WITH LOCALIZED AND ADVANCED PROSTATE CANCER: A CASE-CONTROL STUDY NESTED WITHIN THE UK POPULATION-BASED PROTECT (PROSTATE TESTING FOR CANCER AND TREATMENT) STUDY
מאת: Collin, S, et al.
יצא לאור: (2009)

Ethics of clinical trials from bayesian perspective: randomisation to clinical trials may solve dilemma of treatment choice in prostate cancer.
מאת: Hamdy, F, et al.
יצא לאור: (2003)

The protect trial - Evaluating the effectiveness of treatments for clinically localised prostate cancer and associated molecular and genetic epidemiology studies
מאת: Lane, J, et al.
יצא לאור: (2007)

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer
מאת: Donovan, J, et al.
יצא לאור: (2016)

Understanding and improving recruitment to randomised controlled trials: Qualitative research approaches.
מאת: Elliott, D, et al.
יצא לאור: (2017)

A review of reporting of participant recruitment and retention in RCTs in six major journals
מאת: Tomlin Zelda, et al.
יצא לאור: (2009-07-01)

Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the protecT randomised controlled trial according to treatment received
מאת: Neal, D, et al.
יצא לאור: (2019)

Longitudinal prostate-specific antigen reference ranges: Choosing the underlying model of age-related changes
מאת: Simpkin, A, et al.
יצא לאור: (2013)

Contribution of a single repeat PSA test to prostate cancer risk assessment: experience from the ProtecT study.
מאת: Rosario, D, et al.
יצא לאור: (2008)

Associations of sexual dysfunction symptoms with PSA-detected localised and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
מאת: Collin, S, et al.
יצא לאור: (2009)

Polygenic prediction of occupational status GWAS elucidates genetic and environmental interplay in intergenerational transmission, careers and health in UK Biobank
מאת: Akimova, ET, et al.
יצא לאור: (2024)

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC)
מאת: Julia Wade, et al.
יצא לאור: (2017-07-01)

Prostate-specific antigen testing rates remain low in UK general practice: a cross-sectional study in six English cities.
מאת: Williams, N, et al.
יצא לאור: (2011)